EARLIPOINT ASSESSMENT
"EARLIPOINT ASSESSMENT" is a word mark owned by Earlitec Diagnostics, Inc., filed at the USPTO on October 18, 2026. It is under examination and covers classes 9, 10, 42 and 44.
- Status
- Under examination
- Since October 18, 2026
- Filed
- October 18, 2026
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 50167871
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 4 classes
Who owns EARLIPOINT ASSESSMENT
The owner and representative on file with the office.
Owner
Earlitec Diagnostics, Inc.
Plymouth, United States
Representative
Christopher D. Olszyk, Jr.
Fox Rothschild LLP
What the mark covers
The products and services EARLIPOINT ASSESSMENT is filed for, grouped by Nice class.
Downloadable or recorded software for use in enabling objective diagnosis, tracking of symptoms, and measuring outcomes for individuals having autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Downloadable or recorded software for biometric data analytics; Downloadable or recorded software for collection and analysis of eye-tracking, blink data and other human biometric data; downloadable or recorded software for displaying stimuli to users and collecting eye-movement, blink, and other data in response thereto; Scientific apparatus, namely, apparatus for displaying stimuli to users and collecting eye-movement, blink, and other data in response thereto, not for medical use.; downloadable or recorded software for detecting, assessment, screening, monitoring, or diagnosis of autism spectrum and other neurodevelopmental or cognitive conditions and disorders
Medical device for use in enabling objective diagnosis, tracking of symptoms, and measuring outcomes for individuals having autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Medical device, namely, a device for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; medical device for assessment, screening, monitoring, or diagnosis of autism spectrum and other neurodevelopmental or cognitive conditions and disorders; medical device for collection and analysis of eye-tracking and blink data and other human biometric data; medical eye-tracking and blink-detection device for detecting autism spectrum and other neurodevelopmental or cognitive conditions and disorders
Platform as a service (PAAS) featuring computer software platforms for use in enabling objective diagnosis, tracking of symptoms, and measuring outcomes for individuals having autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Software as a service (SAAS) service featuring software for human biometric data management, data synchronization, data analytics, data automation, and data integration; Computer services, namely, providing data as a service (DaaS) featuring software for collecting, analyzing, integrating, transforming and providing access to human biometric data and information; Providing online non-downloadable software for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; Software as a service (SaaS) services featuring software for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; Platform as a service (PAAS) featuring computer software platforms for detecting and assessing autism spectrum and other neurodevelopmental conditions and disorders; Providing online non-downloadable software for assessment, screening, monitoring, or diagnosis of autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Providing online non-downloadable software for collection and analysis of eye-tracking, blink data, and other human biometric data; providing online non-downloadable software for displaying stimuli to users and collecting eye-movement, blink, and other human biometric data in response thereto; Artificial intelligence as a service (AIAAS) featuring software using artificial intelligence for analyzing data and interacting with humans.
Medical testing services for the purpose of enabling objective diagnosis, tracking of symptoms, and measuring outcomes for individuals having autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Medical testing for diagnostic assessment, detecting and treatment in the field of autism spectrum and other neurodevelopmental conditions and disorders; Providing information in the field of autism spectrum and other neurodevelopmental conditions and disorders; Assessing, screening, monitoring, or diagnosing of autism spectrum and other neurodevelopmental or cognitive conditions and disorders; Collecting and analyzing eye-tracking and blink data for detection of autism spectrum and other neurodevelopmental conditions and disorders.
What has happened so far
Steps recorded by the USPTO, newest first.
- Application filing receipt mailed
- New application entered
About EARLIPOINT ASSESSMENT
Who owns the trademark "EARLIPOINT ASSESSMENT"?
The USPTO trademark "EARLIPOINT ASSESSMENT" (application 50167871) is owned by Earlitec Diagnostics, Inc.
What is the status of "EARLIPOINT ASSESSMENT"?
Its status at the USPTO is: under examination.
Get this data via the API
Everything on this page comes from the Signa API. Pull EARLIPOINT ASSESSMENT and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_01a15442-c68c-75d9-916a-288f49ce2000
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_01a15442-c68c-75d9-916a-288f49ce2000",
"object": "trademark",
"mark_text": "EARLIPOINT ASSESSMENT",
"status": {
"primary": "pending",
"stage": "examining"
},
"office_code": "US",
"application_number": "50167871",
"filing_date": "2026-10-18",
"nice_classes": [
9,
10,
42,
44
],
"owners": [
{
"name": "Earlitec Diagnostics, Inc.",
"entity_id": null
}
]
}